CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors SPECT and PET in ischemic heart failure Modifiable lifestyle factors and heart failure: A Mendelian randomization study Primary Prevention of Heart Failure in Women Heart Failure and Atrial Fibrillation, Like Fire and Fury A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure

Clinical Trial2018 Jun 12;71(23):2628-2639.

JOURNAL:J Am Coll Cardiol. Article Link

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study

Kosiborod M, Lam CSP, CVD-REAL Investigators and Study Group. Keywords: SGLT-2 inhibitor; death; diabetes mellitus; heart failure; observational studies; sodium glucose cotransporter-2 inhibitors

FULL TEXT PDF